Abstract
A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
| Original language | English |
|---|---|
| Pages (from-to) | 328-329 |
| Number of pages | 2 |
| Journal | Clinical Nuclear Medicine |
| Volume | 33 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2008 |
| Externally published | Yes |
Fingerprint
Keywords
- Medullary thyroid cancer
- Metaiodobenzylguanidine (MIBG)
- Multiple endocrine neoplasia
- Phaeochromocytoma
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology
Cite this
Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma. / Newton, Tom Douglas; Augustine, Titus; Arumugam, Parthiban; Malik, Rayaz.
In: Clinical Nuclear Medicine, Vol. 33, No. 5, 05.2008, p. 328-329.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma
AU - Newton, Tom Douglas
AU - Augustine, Titus
AU - Arumugam, Parthiban
AU - Malik, Rayaz
PY - 2008/5
Y1 - 2008/5
N2 - A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
AB - A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
KW - Medullary thyroid cancer
KW - Metaiodobenzylguanidine (MIBG)
KW - Multiple endocrine neoplasia
KW - Phaeochromocytoma
UR - http://www.scopus.com/inward/record.url?scp=42549157082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42549157082&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e31816a7a4d
DO - 10.1097/RLU.0b013e31816a7a4d
M3 - Article
VL - 33
SP - 328
EP - 329
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 5
ER -